Position in GRFS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,459
+$1,194 QoQ
Shares Held
182
+691.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisory Services Network, LLC holds $183,934,456 across 14 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
51,131 | $61,328,051 | |
| 2 | ABBV |
AbbVie Inc.
|
122,841 | $30,911,698 | |
| 3 | JNJ |
Johnson & Johnson
|
85,398 | $21,688,522 | |
| 4 | MRK |
Merck & Co., Inc.
|
149,977 | $19,272,040 | |
| 5 | AMGN |
Amgen Inc
|
33,595 | $12,165,414 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
62,484 | $7,894,217 | |
| 7 | PFE |
Pfizer Inc
|
278,148 | $6,697,795 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
114,609 | $6,603,761 |
All Filings in GRFS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,459 | 182 | Shares | Sole | 2026-05-15 | |
| 2023-12-31 | $265 | 23 | Shares | Sole | 2024-02-09 | |
| 2021-06-30 | $1,474 | 85 | Shares | Sole | 2021-08-12 | |
| 2020-12-31 | $0 | 0 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,787 | 103 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $9,163 | 455 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||